和邦生物补缴税款 预计将影响年度归母净利润7147.4万元

Core Points - The company, Hebang Biotechnology (603077.SH), announced the need to pay a total of 71.474 million yuan in corporate income tax and late fees for the period from January 1, 2023, to December 31, 2023 [1] - As of the date of the announcement, the company has completed the payment of the aforementioned tax and late fees, and this matter does not involve any administrative penalties [1] - The payment of the tax and late fees will be recorded in the company's 2025 financial results, with an expected impact of 71.474 million yuan on the net profit attributable to shareholders of the listed company for the year 2025, subject to the final audited financial statements for that year [1]